• About us
• Contact

Advertisement

Organisation › Details

Pharmasset Inc.

https://www.pharmasset.com
Link has been incorrect on 2014-06-26

Pharmasset is a clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections. Pharmasset's primary focus is the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. Pharmasset's research and development efforts are focused on nucleoside/tide analogs, a class of compounds which act as alternative substrates for the viral polymerase, thus inhibiting viral replication. *

 

	Start	2004-02-16 existent
	End	2012-01-17 acquired
	Group	Gilead Sciences (Group)
	Today	Gilead Sciences (Group)
	Successor	Gilead Sciences (Group)
	Industry	virostatic agent
	Industry 2	sofosbuvir
	Region	Atlanta, GA
	Country	United States (USA)
	City	Atlanta, GA
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for »About Section«:
		Record changed: 2023-07-10

Advertisement

More documents for Gilead Sciences (Group)

• [1] Gilead Sciences, Inc.. (2/1/24). "Press Release: Ted Love, MD, Joins Gilead Sciences’ Board of Directors". Foster City, CA....
• [2] Hookipa Pharma Inc.. (12/21/23). "Press Release: Hookipa Pharma Announces $21.25 Million Equity Investment from Gilead Sciences". New York, NY & Vienna....
• [3] Gilead Sciences, Inc.. (8/15/23). "Press Release: Gilead and Tentarix to Discover and Develop Novel Therapies to Address Unmet Medical Needs Across Cancer and Inflammation". Foster City, CA & San Diego, CA....
• [4] Galapagos N.V.. (6/15/23). "Press Release: Galapagos Appoints Thad Huston as Chief Financial Officer and Chief Operating Officer". Mechelen....
• [5] Hookipa Pharma Inc.. (1/4/23). "Press Release: Hookipa Pharma Achieves $5 Million Milestone Payment from Gilead Sciences for Progress in the Development of Hepatitis B Vaccine". New York, NY & Vienna....
• [6] Gilead Sciences, Inc.. (12/23/22). "Press Release: Gilead Sciences to Present at Upcoming Investor Conference". Foster City, CA....
• [7] Gilead Sciences, Inc.. (12/20/22). "Press Release: Kite to Acquire Tmunity Therapeutics to Pursue Next Generation CAR T-Cell Therapy Advancements in Cancer". Santa Monica, CA & Philadelphia, PA....
• [8] Gilead Sciences, Inc.. (9/20/22). "Press Release: Gilead Sciences Completes Acquisition of MiroBio". Foster City, CA....
• [9] MiroBio Ltd.. (8/4/22). "Press Release: Gilead Sciences to Acquire MiroBio". Foster City, CA & Oxford....
• [10] Galapagos N.V.. (8/30/21). "Press Release: Galapagos Announces Planned Retirement of CEO". Mechelen....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.